SH / EAHP 2017 SCHEDULE FOR ORAL CASE PRESENTATIONS

Welcome and introduction
Genetic Predisposition Syndromes In Myeloid Malignancies                                        Lecture: Lucy Godley

Session 1: Germline Predisposition Syndromes                                                        Thursday, 8:40 - 10:35 am

SH2017-0283

Dr. Rena Xian

Familial AML with germline CEBPA mutation

SH2017-0039

Dr. Karen Chisholm

MDS arising in a 13-year-old with RUNX1 familial platelet disorder

SH2017-0307

Dr. Chollada Curry

Relapsed pediatric myelodysplastic syndrome with a germline GATA2 heterozygous deletion, monosomy 7, and somatic CRLF2 mutation

SH2017-0042

Dr. Craig Soderquist

Myeloproliferative disorder, ET-like, associated with germline SH2B3 mutation

SH2017-0106

Dr. Sunita Park

Familial Burkitt lymphoma reveals X-linked lymphoproliferative disease (XLP)

SH2017-0167

Dr. Chelsey Part Therapy-related Acute Myeloid Leukemia in a Patient with Li-Fraumeni Syndrome

SH2017-0275

Dr. Cecilia Young

Mild Megakaryocyte Atypia in a Patient with Presumed Germline GATA2 Mutation, and Disseminated Mycobacterial Infection.

Session 1 Summary - Olga Weinberg

Fundamentals of Next Generation Sequencing: Technologies and Applications             Lecture: Eric Duncavage

Molecular Genetics of Small Mature B-Cell Lymphomas                                                 Lecture: Elias Campo

Seattle Genetics Lunch Symposium: Lymphoma Pathogenesis as the Ultimate Diagnostic and Therapeutic Guidance

Session 2: Genetic Testing in Diagnosis of Lymphoid Neoplasms                         Thursday, 1:30 - 3:25 pm

SH2017-0160

Dr. Todd. Williams

Entire exome sequencing or high grade B cell lymphoma with BCL2 / MYC rearrangements reveals actionable mutations and antecedent follicular lymphoma

SH2017-0137

Dr. Katrin Huettl

An Aggressive Burkitt-Like Lymphoma With 11q Aberration

SH2017-0341

Dr. Nidhi Aggarwal

Large B-cell lymphoma with IRF4 rearrangement in a 63-year-old male

SH2017-0334

Dr. Pallavi Khattar

t (14:18) negative follicular lymphoma (FL) with 1p36 deletion associated with in situ follicular neoplasia (ISFN) with t (14:18) translocation.

SH2017-0111

Dr. David Wu

STAT3 mutated T-LGL, donor derived, post-cord transplant for T lymphoblastic leukemia

SH2017-0277

Dr. Caleb Ho

Comprehensive Molecular Profiling of an ALK Negative, Anaplastic Large Cell Lymphoma with DUSP22 rearrangement

SH2017-0377

Dr. Philippe Gaulard

Clonal evolution of a TET2 mutated-angioimmunoblastic T-cell lymphoma towards an EBV-associated TFH PTCL

Session 2 Summary

Fundamentals of Next-Generation Sequencing: Analysis and Interpretation                Lecture: Frank Kuo

Session3: Genetic Testing in Diagnosis of Acute Leukemias                             Thursday, 4:15 - 6:10 pm

SH2017-0180

Dr. Keyur Patel

Acute Myeloid Leukemia (Promyelocytic), with Novel IRF2BP2-RARA Fusion

SH2017-0281

Dr. James Bauer

Acute myeloid leukemia with RUNX1 and several co-mutations

SH2017-0299

Dr. Ashley Bird

De novo acute myeloid leukemia with BCR-ABL1

SH2017-0328

Dr. Kenneth Holder

Therapy-related acute myeloid leukemia with monocytic differentiation and MLL gene rearrangement after treatment for acute promyelocytic leukemia

SH2017-0108

Dr. Emily Mason

B lymphoblastic leukemia arising in a patient with a history of lymphoplasmacytic lymphoma

SH2017-0366

Dr. Marian Harris

Pediatric B-ALL with iAMP21

SH2017-0343

Dr. Sarah Ondrejka

Ph-like B-lymphoblastic leukemia, with a kinase-activating alteration

Session 3 Summary

Clinical Significance of Somatic Mutations in Hematologic Neoplasia                            Lecture: Benjamin Ebert

Session 4: Genetic Testing in Diagnosis or Myeloid Neoplasms (Excluding Acute Leukemia) Friday, 8:30 - 10:25 am

SH2017-0124

Dr. John Goodlad

A case of persistent neutrophilia: BCR-ABL negative

SH2017-0351

Dr. Madhu Menon

Chronic myelomonocytic leukemia with molecular abnormalities

SH2017-0156

Dr. Jeffrey Craig

Unmasking or Multiorgan Involvement by Systemic Mastocytosis

SH2017-0171

Dr. Shunyou Gong

Juvenile myelomonocytic leukemia with competitor somatic KRAS and PTPN11 Mutations in A Child Harboring Germline ASXL1 Mutation

SH2017-0376

Dr. Magdalena Czader

Myeloid neoplasm with PCM1-JAK2 presenting with hepatosplenomegaly

SH2017-0300

Dr. Geetha Jagannathan

Chronic Eosinophilic Leukemia, NOS Diagnosed by Next Generation Sequencing

SH2017-0314

Dr. Habibe Kurt

Blastic Plasmacytoid Dendritic Cell Neoplasm with TET2 and DNMT3A mutations

Session 4 Summary

Session 5: Pre-Malignant Clonal Proliferations                                                        Friday, 10:45 am - 12:30 pm

SH2017-0269

Dr. Adam Wood

Probable early myelodysplastic syndrome

SH2017-0050

Dr. Mary-Ann Thompson Arildsen

Pancytopenia in a 38-year-old male: ICUS to CCUS to MDS

SH2017-0350

Dr. Vignesh Shanmugam

Clonal Cytopenia or Undetermined Significance Progressing to ASXL1 and SF3B1 -mutated CMML-1 with Ring Sideroblasts

SH2017-0028

Dr. Anwar Rjoop Incidental myeloid sarcoma diagnosed in a patient with ASXL1 + lymphoplasmytic lymphoma

SH2017-0256

Dr. Saham Loghavi

Incidental MYD88 p.L265P Mutation: a Clue to Competitor B-Cell Lymphoma in a Patient with Chronic Myelomonocytic Leukemia

SH2017-0332

Dr. Lena Stuart

TP53 mutation in a patient with paroxysmal nocturnal hemoglobinuria

Session 5 Summary
Archer Diagnostics Lunch Symposium

Session 6: Genetics Revealing the Biology of Myeloid Neoplasms (Excluding Acute Leukemias)  Friday, 3:20 - 5:05 pm

SH2017-0068

Dr. Yahya Al-Ghamdi

46 year old male with CML in blast crisis with t (15; 17) and RARA gene rearrangement

SH2017-0244

Dr. Pawel Mroz

Myelodysplastic syndrome (MDS) associated with primary mediastinal germ cell tumor

SH2017-0267

Dr. Larissa Liontos

Myeloid neoplasm with morphological features of atypical CML and NPM1 mutation

SH2017-0207

Dr. Anna Nam

Progression of a JAK2 V617F-Positive Essential Thrombocythemia (ET) to a JAK2- V617F-Negative Post-ET Myelofibrosis in Accelerated Phase

SH2017-0238

Dr. Leonardo Boiocchi

Unexpected detection of SF3B1 mutation and ring pageoblasts in a JAK2 + pure myeloproliferative neoplasm

SH2017-0159

Dr. Natasha Lewis

Myeloid neoplasm with del (5q) and SF3B1 and MPL gene mutations

Session 6 Summary

Therapy-Related Myeloid Neoplasms: When Genetics and Environment Collide          Lecture: Megan McNerney

Session 7: Genetics Revealing the Biology of Acute Leukemias                                    Saturday, 8:30 - 10:15 am

SH2017-0057

Dr. Jason Aynardi

Acute Myeloid Leukemia with JAK2 V617F Mutation

SH2017-0094

Dr. Jessica Snider

NUP214-ABL1 fusion: A novel discovery in acute myelomonocytic leukemia

SH2017-0144

Dr. Siddharth Bhattacharyya

Differentiated response to FLT3 inhibition (Quizartinib / AC220) in acute myeloid leukemia is affected by baseline molecular genetics and cytogenetics

SH2017-0119

Dr. Sarah Choi

A 22-year-old male with a Ph-like mixed phenotype acute leukemia (B / myeloid)

SH2017-0148

Dr. Madhu Ouseph

AML with myelodysplasia-related changes and cryptic t (8; 16) (p11; p13); KAT6A / CREBBP

SH2017-0203

Dr. Rebecca Leeman-Neill

Acute leukemia or ambiguous lineage in a pediatric patient with a NUP98-NSD1 rearrangement

Session 7 Summary

Novel Insights into the Molecular Pathogenesis of T-cell Lymphomas                    Lecture:  Kojo Elenitoba-Johnson

Session 8: Genetics Revealing the Biology of Lymphoid Neoplasms                             Saturday, 11:05 am - 12:50 pm

SH2017-0086

Dr. Leticia Quintanilla-Fend

Leukemic non-nodal MCL with complex karyotype and TP53 deletion and mutation with rather indolent clinical behavior.

SH2017-0327

Dr. Rohit Gulati

Leukemic non-nodal MCL with complex karyotype and TP53 deletion and mutation with rather indolent clinical behavior

SH2017-0338

Dr. Andrew Evans

IGH sequencing distinguishes multiple EBV + mucocutaneous ulcers from recurrent malignant diffuse large B cell lymphoma

SH2017-0359

Dr. Shiraz Fidai

Progression of CLL with two Richter transformations associated with two different MYC rearrangements

SH2017-0210

Dr. Jonathon Gralewski

Myeloid Sarcoma with Monocytic Differentiation and IGH-MAF Gene Reaction

SH2017-0035

Dr. Mariusz Wasik

Mantle cell lymphoma trans-differentiated into poorly differentiated sarcoma with evidence of muscle and neutral differentiation

Session 8 Summary
Wrokshop Concluding remarks

More about



Sign in